Chronic ACL Injury Drives a Fibrotic and Matrix-Degradative Shift: A Multi-Level Analysis of MMP-13 and TGF-β1
Medicina · 2026
DOI: 10.3390/medicina62030457 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicina, 2026. Verfasst von Yılmaz Mertsoy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Orthopedics, Gazi Yasargil Training and Research Hospital, 21090 Diyarbakır, Turkey. Hauptthemen laut MEDLINE: Anterior Cruciate Ligament Injuries, Matrix Metalloproteinase 13, Transforming Growth Factor beta1. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Objectives: The biological state of anterior cruciate ligament (ACL) remnant tissue may influence postoperative healing, yet the molecular changes associated with injury chronicity remain poorly defined. This study evaluated MMP-13 and TGF-β1 expression in human ACL remnants to characterize their regenerative or fibrotic potential. Materials and Methods: ACL remnants from acute (6 months) injuries were analyzed using histology, immunohistochemistry, and QuPath-based digital quantification. Clinical outcomes were correlated with marker expression. Protein–protein interaction and KEGG enrichment analyses were performed to identify extracellular matrix (ECM)-related pathways associated with MMP-13 and TGF-β1.
Results
Chronic ACL remnants exhibited disorganized ECM structure with significantly higher MMP-13 and TGF-β1 expression across all digital metrics, including DAB-positive area, cell density, optical density, and H-score (p < 0.01). Higher expression of both markers correlated with lower IKDC and Lysholm scores and greater residual pivot-shift positivity. Bioinformatic analysis identified 39 shared proteins enriched in ECM-receptor interaction, TGF-β signaling, and fibrosis-related pathways, aligning with the degenerative phenotype observed in chronic tissue.
Conclusions
ACL remnant biology evolves from a reparative profile in acute injuries to a fibrotic, matrix-degradative state in chronic injuries. MMP-13 and TGF-β1 serve as indicators of remnant quality and may help guide timing of surgery and future biologic strategies aimed at improving ACL reconstruction outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Orthopedics, Gazi Yasargil Training and Research Hospital, 21090 Diyarbakır, Turkey.
- Division of Medical Pathology, Gazi Yasargil Training and Research Hospital, 21090 Diyarbakır, Turkey.
ORCID-Profile: Sözdar Güzel, Alpay Çetin
Zitieren
APA
Mertsoy, Y., Altıntaş, M., Güzel, S., & Çetin, A. (2026). Chronic ACL Injury Drives a Fibrotic and Matrix-Degradative Shift: A Multi-Level Analysis of MMP-13 and TGF-β1. Medicina. https://doi.org/10.3390/medicina62030457
Vancouver
Mertsoy Y, Altıntaş M, Güzel S, Çetin A. Chronic ACL Injury Drives a Fibrotic and Matrix-Degradative Shift: A Multi-Level Analysis of MMP-13 and TGF-β1. Medicina. 2026. doi:10.3390/medicina62030457
BibTeX
@article{Mertsoy2026,
author = {Mertsoy, Yılmaz and Altıntaş, Mustafa and Güzel, Sözdar and Çetin, Alpay},
title = {Chronic ACL Injury Drives a Fibrotic and Matrix-Degradative Shift: A Multi-Level Analysis of MMP-13 and TGF-β1},
journal = {Medicina},
year = {2026},
doi = {10.3390/medicina62030457}
}
EUVIMED